SEARCH

SEARCH BY CITATION

References

  • 1
    Sweetnam R. Osteosarcoma. Br J Hosp Med. 1982; 28:112, 16-21.
  • 2
    Mascarenhas L, Siegel S, Spector L, Arndt C, Femino D, Malogolowkin M. Malignant bone tumors: cancer in 15- to 29-year-olds in the United States. In: Bleyer A, OLM, Barr R, Ries LAG, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. Bethesda, Md: National Cancer Institute; 2006: 98-109. NIH Pub. No. 06-5767.
  • 3
    Dahlin DC, Unni KK. Bone Tumors: General Aspects and Data on 8,542 Cases, 4th ed. Springfield, Ill: Thomas; 1986.
  • 4
    Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma. National Cancer Data Base report. Clin Orthop Relat Res. 2007; 459: 40-47.
  • 5
    Dorfman HA, Czerniak B. Bone cancers. Cancer. 1995; 75( 1 suppl): 203-210.
  • 6
    Kramarova E, Stiller CA. The International Classification of Childhood Cancer. Int J Cancer. 1996; 68: 759-765.
  • 7
    Fletcher CDM, Unni KK, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Soft Tissue and Bone. Lyon, France: IARC Press; 2002.
  • 8
    Unni KK. Osteosarcoma. In: Dahlin DC, ed. Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases, 5th ed. Philadelphia, Pa: Lippincott-Raven; 1996: 143-183.
  • 9
    Dorfman HA, Czerniak B. Bone Tumors. St Louis, Mo: Mosby; 1997.
  • 10
    Price CHG. Osteogenic sarcoma: an analysis of the age and sex incidence. Br J Cancer. 1955; 9: 558-574.
  • 11
    Sabanas AO, Dahin DC, Childs DS, Ivings JC. Postirradiation sarcoma of bone. Cancer. 1956; 9: 528-542.
  • 12
    Murray RO. Tumor and tumor-like lesions of bone. In: Sutton D, Grainger AG, eds. A Textbook of Radiology, 2nd ed. New York, NY: Churchill Livingstone; 1975: 109-137.
  • 13
    Huvos AG. Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years. Cancer. 1986; 57: 1442-1449.
  • 14
    Hayden JB, Hoang BH. Osteosarcoma: basic science and clinical implications. Orthop Clin North Am. 2006; 37: 1-7.
  • 15
    Gurney JG, Swensen AR, Bulterys M. Malignant bone tumors. In: Reis LAG, Smith MA, Gurney JG, et al, eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program, 1975-1995. Bethesda, Md: National Cancer Institute SEER Program; 1999: 99-110. NIH Pub. No. 99-4649.
  • 16
    Polednak AP. Human biology and epidemiology of childhood bone cancers: a review. Hum Biol. 1985; 57: l-26.
  • 17
    Hanson MR, Mulvihill JJ. Epidemiology of Cancer in the Young. New York, NY: Masson; 1982.
  • 18
    Glass AG, Fraumeni JF. Epidemiology of bone cancer in children. J Natl Cancer Inst. 1970; 44: 187-199.
  • 19
    Kramer S, Meadows AT, Jarret P, Evans AE. Incidence of childhood cancer: experience of a decade in a population-based registry. J Natl Cancer Inst. 1983; 70: 49-55.
  • 20
    Young JL Jr, Ries LG, Silverberg E, Horn JW, Miller RW. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. 1986; 58: 598-602.
  • 21
    Homa DM, Sowers MR, Schwartz AG. Incidence and survival rates of children and young adults with osteogenic sarcoma. Cancer. 1991; 67: 2219-2224.
  • 22
    Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Cancer. 1995; 75: 2186-2195.
  • 23
    Gatta G, Capocaccia R, Coleman MP, Ries LAG, Berrino F. Childhood cancer survival in Europe and the United States. Cancer. 2002; 95: 1767-1772.
  • 24
    Foster L, Dall GF, Reid R, Wallace WH, Porter DE. Twentieth-century survival from osteosaroma in children: trends from 1933 to 2004. J Bone Joint Surg. 2007; 89-B: 1234-1238.
  • 25
    Herzog CE. Overview of sarcomas in the adolescent and young adult population. J Pediatr Hematol Oncol. 2005; 27: 215-218.
  • 26
    Parkin DM, Stiller CA, Draper GJ, Bieber CA. The international incidence of childhood cancer. Int J Cancer. 1988; 42: 511-520.
  • 27
    Ajiki W, Hanai A, Tsukuma H, Hiyama T, Fujimoto I. Survival rates of childhood cancer patients in Osaka, Japan, 1975-1984. Jpn J Cancer Res. 1995; 86: 13-20.
  • 28
    Novakovic BUS. Childhood cancer survival, 1973-1987. Med Pediatr Oncol. 1994; 23: 480-486.
  • 29
    Larsson SE, Lorentzon R. The incidence of malignant primary bone tumors in relation to age, sex, and site: a study of osteogenic sarcoma, chondrosarcoma, and Ewing's sarcoma diagnosed in Sweden from 1958 to 1968. J Bone Joint Surg. 1974; 56B: 534-540.
  • 30
    Polednak AP. Primary bone cancer incidence in black and white residents of New York state. Cancer. 1985; 55: 2883-2888.
  • 31
    Blackwell JB, Threlfall TJ, McCaul KA. Primary malignant bone tumours in Western Australia, 1972-1996. Pathology. 2005; 37: 278-283.
  • 32
    Ji J, Hemminki K. Familial risk for histology-specific bone cancers: an updated study in Sweden. Eur J Cancer. 2006; 42: 2343-2349.
  • 33
    Linabery AM, Ross JA. Trends in childhood cancer incidence in the US (1992-2004). Cancer. 2007; 112: 416-432.
  • 34
    Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. SEER Registries: Surveillance Research Program, National Cancer Institute. Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2007. Available at: http://seer.cancer.gov/registries/ Accessed on November 25, 2008.
  • 35
    Surveillance Research Program. National Cancer Institute SEER*Stat Software, version 6.3.6. Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2007.
  • 36
    Day JC. Population Projections of the United States by Age, Sex, Race and Hispanic Origin, 1995 to 2050, US Bureau of the Census, Current Population Reports, P25-1130. Washington, DC: US Government Printing Office; 1996.
  • 37
    World Health Organization. International Classification of Diseases for Oncology, 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
  • 38
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 13 Regs Limited-Use, November 2006 Submission (1992-2004)-Linked to County Attributes-Total US, 1969-2004 Counties. Bethesda, Md:National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2007, based on the November 2006 submission.
  • 39
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Limited-Use, November 2006 Submission (1973-2004)-Linked to County Attributes-Total US, 1969-2004 Counties. Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2007, based on November 2006 submission.
  • 40
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 17 Regs Limited-Use, November 2006 Submission (1973-2004 varying)-Linked to County Attributes-Total US, 1969-2004 Counties. Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2007, based on the November 2006 submission. Available at: www.seer.cancer.gov. [Access date].
  • 41
    Miller RW. Contrasting epidemiology of childhood osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. Nat Cancer Inst Monogr. 1981; 56: 9-15.
  • 42
    Hamre MR, Severson RK, Chuba P, Lucas DR, Thomas RL, Mott MP. Osteosarcoma as a second malignant neoplasm. Radiother Oncol. 2002; 65: 153-157.
  • 43
    Grimer RJ, Cannon SR, Taminiau AM, et al. Osteosarcoma over the age of forty. Eur J Cancer. 2003; 39: 157-163.
  • 44
    Healey JH, Buss D. Radiation and pagetic osteogenic sarcomas. Clin Orthop Relat Res. 1991; 270: 128-134.
  • 45
    Hanson MF, Seton M, Merchant A. Osteosarcoma in Paget's disease of bone. J Bone Mineral Res. 2006; 21( suppl 2): P58-P63.
  • 46
    Okada K, Hasegawa T, Nishida J, et al. Osteosarcomas after the age of 50: a clinicopathologic study of 64 cases—an experience in northern Japan. Ann Surg Oncol. 2004; 11: 998-1004.
  • 47
    deSantos LA, Rosengren JE, Wooten WB, Murray JA. Osteogenic sarcoma after the age of 50: a radiographic evaluation. AJR Am J Roentgenol. 1978; 131: 481-484.
  • 48
    Weinfield MS, Dudley HR. Osteogenic sarcoma: a follow-up study of the 94 cases observed at the Massachusetts General Hospital from 1920-1960. J Bone Joint Surg. 1962; 44: 269-276.
  • 49
    Aegerter E, Kirkpatrick JA. Orthopedic Disease, 4th ed. Philadelphia, Pa: Saunders, 1975.
  • 50
    Dahlin DC, Coventry MB. Osteogenic sarcoma: a study of 6 hundred cases. J Bone Joint Surg. 1967; 49A: 101-110.
  • 51
    Taylor WF, Ivins JC, Pritchard DJ, Dahlin DC, Gilchrist GS, Edmonson JH. Trends and variability in survival among patients with osteosarcoma: a 7-year update. Mayo Clin Proc. 1985; 60: 91-104.
  • 52
    Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M; the EUROCARE Working Group. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol. 2005; 23: 3742-3751.
  • 53
    Ferrari S, Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol. 2007; 19: 341-346.